CERo Therapeutics Holdings, Inc. - Common Stock (CERO)

About CERo Therapeutics Holdings, Inc. - Common Stock (CERO)

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in South San Francisco, CA.

CERo Therapeutics Holdings, Inc. - Common Stock News